It is a pharma private limited company based in Bengaluru, Karnataka, India, established in 2012.
2012 | Bengaluru, Karnataka, India | ActiveSceolex Pharma Private Limited, a active private limited company, was established on 13 November 2012 in Bengaluru, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24110KA2012PTC066676. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Bellur Mekhala Dwarakanath (Director), Sankara Guha Dwarakanath Bellur (Director), Surayanarayanarao Savithri (Director). Past directors included Arun Nagesh Avadhani, Muniswamaiah Krishnamurthy, Raju Chowdappa Raghavendra. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 135/2, Bearing Bbmp Khatha, No. 18, Guava Garden, 5Th Block, Koramangala, Bengaluru, Karnataka, 560095.
U24110KA2012PTC066676
066676
13 November 2012
₹2.00 M
₹2.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Sceolex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bellur Mekhala Dwarakanath | Director | 01 Nov 2013 | Current |
| Sankara Guha Dwarakanath Bellur | Director | 01 Nov 2013 | Current |
| Surayanarayanarao Savithri | Director | 01 Nov 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 May 2014 | Past |
| Pramod Abcsdd | Director | 01 Nov 2013 | Past |
| Pramod Abcsdd | Director | 09 Jun 2015 | Past |
| Pramod Abcsdd | Additional Director | 10 May 2014 | Past |
| Pramod Abcsdd | Additional Director | 10 May 2014 | Past |
| Pramod Abcsdd | Additional Director | 10 May 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sceolex Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 21.31% decrease. The company also saw a slight improvement in profitability, with a 6.28% increase in profit. The company's net worth observed a substantial decline by a decrease of 399.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Sceolex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sceolex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sceolex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sceolex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sceolex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Sceolex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Bellur Mekhala Dwarakanath was appointed as a Director was appointed as a Director on 01 Nov 2013 & has been associated with this company since 12 years 1 month . was recorded as a recent event.
The activity Sankara Guha Dwarakanath Bellur was appointed as a Director was appointed as a Director on 01 Nov 2013 & has been associated with this company since 12 years 1 month . was completed.
Progress on Surayanarayanarao Savithri was appointed as a Director was appointed as a Director on 01 Nov 2013 & has been associated with this company since 12 years 1 month . was documented.
Sceolex Pharma Private Limited was registered on 13 Nov 2012 with Roc Bangalore & aged 13 years 19 days as per MCA records. was recorded as a recent event.
The CIN of Sceolex Pharma Private Limited is U24110KA2012PTC066676.
Sceolex Pharma Private Limited is headquartered at No. 135/2, Bearing Bbmp Khatha, No. 18, Guava Garden, 5Th Block, Koramangala, Bengaluru, Karnataka, 560095.
Sceolex Pharma Private Limited was incorporated on 13 November 2012.
The current directors of Sceolex Pharma Private Limited are
The primary industry of Sceolex Pharma Private Limited is Trade.
Sceolex Pharma Private Limited is unlisted.
The authorized capital of Sceolex Pharma Private Limited is ₹2.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Sceolex Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX